JP MORGAN/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17.5/1/17.01.25 | Market Closed - Börse Stuttgart 04:00:43 2024-06-25 EDT | ||
| 1.66 EUR | -7.78% |
|
| Current month | -13.09% | ||
| 1 month | -8.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 1.66 | -7.78% |
| 24-06-24 | 1.8 | -7.22% |
| 24-06-21 | 1.94 | +6.01% |
| 24-06-20 | 1.83 | -2.66% |
| 24-06-19 | 1.88 | -3.09% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 04:00 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
| Issuer | J.P. Morgan |
| WKN | JB9Y9P |
| ISIN | DE000JB9Y9P5 |
| Date issued | 2024-01-05 |
| Strike | 17.5 $ |
| Maturity | 2025-01-17 (206 Days) |
| Parity | 1 : 1 |
| Emission price | 0.42 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.15 € |
|---|---|
| Lowest since issue | 0.39 € |
| Delta | 0.55x |
| Omega | 3.904 |
| Premium | 20.08x |
| Gearing | 7.13x |
| Moneyness | 0.9429 |
| Difference Strike | 1 $ |
| Difference Strike % | +5.71% |
| Spread | 1 € |
| Spread % | 37.59% |
| Theoretical value | 2.160 |
| Implied Volatility | 50.92 % |
| Total Loss Probability | 60.39 % |
| Intrinsic value | 0.000000 |
| Present value | 2.160 |
| Break even | 19.81 € |
| Theta | -0.05x |
| Vega | 0.05x |
| Rho | 0.04x |
Company Profile
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
Ratings for Teva Pharmaceutical Industries Limited
Trading Rating
Investor Rating
ESG Refinitiv
B-
Consensus: Teva Pharmaceutical Industries Limited
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.5
USD
Average target price
18.34
USD
Spread / Average Target
+11.13%
- Stock Market
- Warrants
- Warrant
